[미국특허]
Hyaluronic acid derivative gel and method for preparing the same
원문보기
IPC분류정보
국가/구분
United States(US) Patent
공개
국제특허분류(IPC7판)
A61K-031/728
A61K-031/726
C08B-037/00
출원번호
US-0521003
(2003-05-21)
공개번호
US-0166928
(2006-07-27)
우선권정보
KR-10-2002-0044261(2002-07-26)
국제출원번호
PCT/KR03/000998
(2003-05-21)
발명자
/ 주소
Moon,Tae
Kim,Jin
Lee,Jae
Min,Byung
Cho,Kwang
출원인 / 주소
Moon,Tae
Kim,Jin
Lee,Jae
Min,Byung
Cho,Kwang
대리인 / 주소
CANTOR COLBURN, LLP
인용정보
피인용 횟수 :
0인용 특허 :
0
초록▼
The present invention relates to a hyaluronic acid derivative gel, obtained by amidation of a hyaluronic acid, or its cationic salt, and an amine group-containing saccharide compound, having excellent viscoelastic properties, and a method for preparing it. Especially, the hyaluronic acid derivative
The present invention relates to a hyaluronic acid derivative gel, obtained by amidation of a hyaluronic acid, or its cationic salt, and an amine group-containing saccharide compound, having excellent viscoelastic properties, and a method for preparing it. Especially, the hyaluronic acid derivative gel according to the present invention shows responses peculiar to heat and can be made to have various properties by heat treatment. The hyaluronic acid derivative gel according to the present invention can be used for a variety of purposes such as post-operative adhesion-preventing gel, material for wrinkle treatment, auxiliary material for plastic surgery, material for arthritis treatment, and drug delivery vehicle.
대표청구항▼
1. A method for preparing a hyaluronic acid derivative gel, comprising the following steps: (a) mixing a hyaluronic acid, or its cationic salt, and a saccharide compound containing amine groups, and then agitating; (b) activating the carboxyl group of the hyaluronic acid or its cationic salt; and
1. A method for preparing a hyaluronic acid derivative gel, comprising the following steps: (a) mixing a hyaluronic acid, or its cationic salt, and a saccharide compound containing amine groups, and then agitating; (b) activating the carboxyl group of the hyaluronic acid or its cationic salt; and (c) reacting the activated carboxyl group of the hyaluronic acid, or its cationic salt, with the amine group of the saccharide compound. 2. The method according to claim 1, wherein the cationic salt of hyaluronic acid is one or more selected from a group consisting of sodium hyaluronate, potassium hyaluronate, ammonium hyaluronate, calcium hyaluronate, magnesium hyaluronate, and tetrabutylammonium hyaluronate. 3. The method according to claim 1, wherein the final reaction concentration of hyaluronic acid, or its cationic salt, is in the range of between 0.05 mg/ml and 50 mg/ml. 4. The method according to claim 1, wherein the average molecular weight of hyaluronic acid, or its cationic salt, is in the range of between 500,000 and 5,000,000. 5. The method according to claim 1, wherein the amine group-containing saccharide compound is one or more selected from a group comprising of chitosan, chitosan derivatives, deacetylated hyaluronic acid, and deacetylated hyaluronic acid derivatives. 6. The method according to claim 1, wherein said saccharide compound containing amine groups is added in such an amount that the ratio of the amino group to the carboxyl group of the hyaluronic acid is in the range of 0.01:1 to 100:1. 7. The method according to claim 1, wherein activation of the carboxyl groups is accomplished by adding one or more agents for activating carboxyl groups. 8. The method according to claim 7, wherein activation of the carboxyl groups is accomplished by adding one or more compounds, as a main agent, selected from a group consisting of 1-alkyl-3-(3-dimethylaminopropyl)carbodiimides (alkyl herein is alkyl of 1-10 carbon atoms), 1-ethyl-3-(3-(trimethylammonio)propyl)carbodiimide ("ETC") and 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide ("CMC"), and one or more compounds, as an auxiliary agent, selected from a group consisting of 1-hydroxybenzotriazole ("HOBt"), 3,4-dihydro-3-hydroxy-4-oxo-1,2,3-benzotriazine ("HOOBt"), 1-hydroxy-7-azabenzotriazole ("HOAt"), N-hydroxysuccinimide (NHS), and sulfo-NHS. 9. The method according to claim 8, wherein the main activation agent is 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride ("EDC") and the auxiliary activation agent is NHS. 10. The method according to claim 9, wherein EDC is added in a final reaction concentration of between 0.01 mg/ml and 20 mg/ml. 11. The method according to claim 9, wherein NHS is added in a final reaction concentration of between 0.1 mg/ml and 20 mg/ml. 12. The process according to claim 1, further including a step of heat-treating the hyaluronic acid derivative gel produced in step (c) at 25째 C. to 130째 C. for 0.5 hour 144 hours. 13. A hyaluronic acid derivative gel produced by the method in claim 1.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
활용도 분석정보
상세보기
다운로드
내보내기
활용도 Top5 특허
해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다. 더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.